Cargando…

Liver Isolation Oxaliplatin (LIOX): Long Term Survival from a New Locoregional Technique for Chemorefractory Patients with Colorectal Liver Metastases

Detalles Bibliográficos
Autores principales:	Khin, Nyan Y., De Silva, Madhawa, Clarke, Stephen, Pavlakis, Nick, Rogan, Chris M., Ho-Shon, Kevin, Lane, Rodney J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	ASO Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072514/ https://www.ncbi.nlm.nih.gov/pubmed/35147822 http://dx.doi.org/10.1245/s10434-022-11348-z

Ejemplares similares

Genomic mutations and histopathologic biomarkers in Y(90) radioembolization for chemorefractory colorectal liver metastases
por: Dendy, Meaghan S., et al.
Publicado: (2018)

ASO Author Reflections: Towards Consensus on Resectability Assessments and Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases
por: Bond, Marinde J. G., et al.
Publicado: (2023)

ASO Author Reflections: Real-World Conclusions on Locoregionally Recurrent Colon Cancer
por: Swartjes, Hidde, et al.
Publicado: (2022)

Prospective phase II trial of regional hyperthermia and whole liver irradiation for numerous chemorefractory liver metastases from colorectal cancer
por: Yu, Jeong Il, et al.
Publicado: (2016)

ASO Author Reflections: APRI + ALBI: A Novel Tool for Estimating Chemotherapy-Associated Liver Injury in Patients with Colorectal Cancer Liver Metastasis Undergoing Liver Resection
por: Pereyra, D., et al.
Publicado: (2019)

Locoregional treatment for colorectal liver metastases aiming for precision medicine
por: Maki, Harufumi, et al.
Publicado: (2023)

ASO Author Reflections: PIPAC Oxaliplatin in Refractory Colorectal or Appendiceal Carcinomatosis: Encouraging Results from a Phase 1 Clinical Trial
por: Sullivan, Kevin M., et al.
Publicado: (2023)

ASO Author Reflections: The Prognostic Value of Time to Metastasis in Colorectal Liver Metastasis
por: Höppener, Diederik J., et al.
Publicado: (2019)

ASO Visual Abstract: Preventing Futile Liver Resection: A Risk-Based Approach to Surgical Selection in Major Hepatectomy for Colorectal Cancer
por: Fromer, Marc W., et al.
Publicado: (2021)

ASO Author Reflections: Neoadjuvant Systemic Chemotherapy in Isolated Resectable Colorectal Peritoneal Metastases: Ready for Standard of Care?
por: Flood, Michael P., et al.
Publicado: (2022)

ASO Author Reflections: Toward Improved Selection of Patients for Cytoreduction and HIPEC: Identification of Prognostic Factors for Patients with Colorectal Peritoneal Metastases
por: Sluiter, Nina R., et al.
Publicado: (2018)

ASO Author Reflections: Peritoneal Metastases from Endometrial Cancer
por: Sammartino, Paolo, et al.
Publicado: (2018)

Pharmacokinetics and pharmacodynamics of locoregional 5 fluorouracil (5FU) in advanced colorectal liver metastases.
por: Goldberg, J. A., et al.
Publicado: (1988)

ASO Author Reflections: Indocyanine Green Fluorescence Navigation in Liver Surgery: Current Applications and Future Perspectives
por: Liu, Fusheng, et al.
Publicado: (2023)

ASO Author Reflections: The Timing of Onset of Peritoneal Metastases from Colorectal Carcinoma Is Not an Independent Predictor of Survival Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
por: Dietz, Michelle V., et al.
Publicado: (2022)

ASO Author Reflections: Advanced Imaging Allows Better Detection of Peritoneal Metastases
por: Sluiter, Nina Roelie, et al.
Publicado: (2018)

ASO Author Reflections: Clinical Outcome After Upfront Curative-Intent Local Treatment of Metastases in Patient with Deficient Mismatch Repair Versus Proficient Mismatch Repair Metastatic Colorectal Cancer
por: Zwart, Koen, et al.
Publicado: (2023)

Decrease of survivin, p53 and Bcl-2 expression in chemorefractory colorectal liver metastases may be predictive of radiosensivity after radioembolization with yttrium-90 resin microspheres
por: Melucci, Elisa, et al.
Publicado: (2013)

ASO Author Reflections: Dilemma of Paraaortic Lymph Node Metastases During Exploration for Suspected Periampullary Carcinoma
por: Pranger, Bobby K., et al.
Publicado: (2020)

ASO Author Reflections: Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Hepatic Metastases from Ocular Melanoma
por: Meijer, T. Susanna, et al.
Publicado: (2020)

ASO Author Reflections: Risk Stratification of Sentinel Node Metastases in Stage III Melanoma Patients in the Era of Adjuvant Systemic Therapy
por: Hussain, Zahra, et al.
Publicado: (2022)

Safe and Successful Yttrium-90 Resin Microsphere Radioembolization in a Heavily Pretreated Patient with Chemorefractory Colorectal Liver Metastases after Biliary Stent Placement above the Papilla
por: Sotirchos, Vlasios S., et al.
Publicado: (2014)

Chemorefractory liver metastasis from cervical cancer successfully treated with a combination of yttrium-90 and immunotherapy
por: Nance, Michael E., et al.
Publicado: (2020)

Transcatheter Arterial Chemoembolization Is a Feasible Palliative Locoregional Therapy for Breast Cancer Liver Metastases
por: Cho, Sung W., et al.
Publicado: (2010)

Alterations in IQGAP1 expression and localization in colorectal carcinoma and liver metastases following oxaliplatin-based chemotherapy
por: Rotoli, Deborah, et al.
Publicado: (2017)

Hepatectomy Followed by Adjuvant Chemotherapy with 3‐Month Capecitabine Plus Oxaliplatin for Colorectal Cancer Liver Metastases
por: Satake, Hironaga, et al.
Publicado: (2021)

Readministration of Cancer Drugs in a Patient with Chemorefractory Metastatic Colorectal Cancer
por: Kawagoe, Tetsuro, et al.
Publicado: (2020)

ASO Author Reflections: Applications of Artificial Intelligence in Oesophago-Gastric Malignancies—Present Work and Future Directions
por: Chidambaram, Swathikan, et al.
Publicado: (2021)

Clinical and imaging-based prognostic factors in radioembolisation of liver metastases from colorectal cancer: a retrospective exploratory analysis
por: Willowson, Kathy P., et al.
Publicado: (2017)

Aggressive Locoregional Treatment Improves the Outcome of Liver Metastases from Grade 3 Gastroenteropancreatic Neuroendocrine Tumors
por: Du, Shunda, et al.
Publicado: (2015)

Adjuvant oxaliplatin- or irinotecan-containing chemotherapy improves overall survival following resection of metachronous colorectal liver metastases
por: Liu, Jin-Hwang, et al.
Publicado: (2010)

Commitment of Scaffold Proteins in the Onco-Biology of Human Colorectal Cancer and Liver Metastases after Oxaliplatin-Based Chemotherapy
por: Rotoli, Deborah, et al.
Publicado: (2017)

Delta-Radiomics Predicts Response to First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients with Liver Metastases
por: Giannini, Valentina, et al.
Publicado: (2022)

ASO Author Reflections: Enhancing Surgical Decision-Making for Breast Reconstruction—Machine Learning-Driven Prediction of Postoperative Quality of Life
por: Xu, Cai, et al.
Publicado: (2023)

Breakthrough 5-year survival with pembrolizumab in Keynote-001 study: horizon shifting in advanced non-small cell lung cancer with immune check point inhibition
por: de Silva, Madhawa, et al.
Publicado: (2020)

ASO Author Reflections: Postoperative Inflammatory Markers as a Surveillance Tool in Colorectal Peritoneal Carcinomatosis
por: Tan, Joey Wee-Shan, et al.
Publicado: (2021)

ASO Author Reflections: Nationwide Data on Ostomy Use in Elderly Patients After Colorectal Cancer Surgery
por: van Loon, Yu-Ting, et al.
Publicado: (2021)

Bevacizumab plus chemotherapy as salvage treatment in chemorefractory patients with metastatic colorectal cancer
por: Geva, Ravit, et al.
Publicado: (2013)

Gemcitabine plus capecitabine (Gem–Cape) biweekly in chemorefractory metastatic colorectal cancer
por: Jiménez-Fonseca, P., et al.
Publicado: (2014)

ASO Author Reflections: Real-World Effectiveness of Prehabilitation Before Colorectal Cancer Surgery: The Value of an Emulated Target Trial Design
por: Heil, Thea C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jt1cdr5rch46toco8set7f9k9p